US4393071A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating gastric, mammary, lung and uterus tumors
Assignee: Individual
•
Filing: 1981-03-06
•
Granted: 1983-07-12
•
Expires: 2001-03-06
Abstract
Abstract A method of treating malignant tumors by daily administering of between 5 and 100 mg. of protoporphyrin. Preferrably the protoporphyrin is given with a carrier which can be a solid edible material.
Inventors
- 👤 Naoharu Fujii
- 👤 Noboru Iijima
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 04:25
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
43 words
A method of treating in an animal body malignant tumors selected from the group consisting of gastric tumor, mammary tumor, lung tumor, and uterus tumor, comprising the step of daily administering to the animal body of between 5 to 100 mg. of protoporphyrin.
Claim 2
Independent Claim
43 words
A method of treating in an animal body malignant tumors selected from the group consisting of gastric tumor, mammary tumor, lung tumor, and uterus tumor, comprising the step of daily administering to the animal body of between 5 to 100 mg. of protoporphyrin.
Claim 3
Dependent Claim
27 words
A method according to claim 1 wherein said protoporphyrin is administered in a physiologically acceptable salt selected from the group consisting of sodium salt and potassium salts.
Claim 4
Dependent Claim
20 words
A method according to claim 1, wherein said protoporphyrin is administered in the form of a composition with a carrier.
Claim 5
Dependent Claim
11 words
A method according to claim 3, wherein said carrier is solid.
Claim 6
Dependent Claim
14 words
A method according to claim 4, wherein said carrier is a solid edible material.
Claim 7
Dependent Claim
12 words
A method according to claim 3, wherein said carrier is a liquid.
Claim 8
Dependent Claim
36 words
A method according to claim 1, wherein said protoporphyrin is administered in a physiologically acceptable complex selected from the group consisting of titanium complex, iron complex, cobalt complex, germanium complex and their sodium or potassium salts.
Claim 9
Dependent Claim
17 words
A method according to claim 1 wherein said protoporphyrin is given in the amount of 20 mg./day.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-07-11 | 1987-01-10 | 1987-07-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-07-11 | 1991-01-10 | 1991-07-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-07-11 | 1995-01-10 | 1995-07-12 | $7700.00 | Window Closed / Lapsed |